Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac3d61110b450f97ef46e8cf2b1c8552 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
filingDate |
2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40a6f986ef1dd86d2f287baf4b988459 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_565e8ec807b80fdd2d7574674d7ad44f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e370987c4d5162a515a87d020918ffda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8835c44c7be853bbb089ed463d36fd4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a661043390b9e420ae623afa3034772 |
publicationDate |
2019-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3528832-A1 |
titleOfInvention |
Specific ac5 inhibitor |
abstract |
The present invention relates to a polypeptide capable of specifically inhibiting human adenylyl cyclase (5) wherein said polypeptide does essentially not inhibit human adenylyl cyclase (6). The present invention also relates to the polypeptide for use in specifically inhibiting human adenylyl cyclase (5) in a subject. The present invention further relates to an in vitro use of the polypeptide for inhibiting human adenylyl cyclase (5) and an in vitro method for inhibiting human adenylyl cyclase (5). |
priorityDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |